European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on June 30, 2026

Jun. 30, 2026

Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic

Indeterminate GlobeNewswire

Jun. 30, 2026

Crédit Agricole CIB and Pasqal advance their strategic partnership to deploy quantum computing applied to finance

Indeterminate GlobeNewswire

Jun. 30, 2026

SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Indeterminate GlobeNewswire

Jun. 30, 2026

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel

Indeterminate GlobeNewswire

Jun. 30, 2026

Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)

Indeterminate GlobeNewswire

Jun. 30, 2026

American Lithium Minerals, Inc. (OTC: AMLM) Acquires 100% Interest in High Grade New Zealand Gold–Antimony Projects

Indeterminate GlobeNewswire

Jun. 30, 2026

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

Indeterminate GlobeNewswire

Jun. 30, 2026

One Bullion Announces Board Transition

Indeterminate GlobeNewswire

Jun. 30, 2026

InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos

Indeterminate GlobeNewswire

Jun. 30, 2026

Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

Indeterminate GlobeNewswire

Jun. 30, 2026

Corten Capital and Ampersand Capital Partners Complete Acquisition of Beacon Intelligence to Accelerate Growth in Life Sciences R&D Intelligence

Indeterminate GlobeNewswire

Jun. 30, 2026

AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease

Indeterminate GlobeNewswire

Jun. 30, 2026

R1 Therapeutics establishes world-class Scientific Advisory Board to support advancement of AP306 in Chronic Kidney Disease

Indeterminate GlobeNewswire

Jun. 30, 2026

Nomerra raises $2 million to tackle private markets’ looming paperwork crisis

Indeterminate GlobeNewswire

Jun. 30, 2026

Belo Sun Provides Project Update

Indeterminate GlobeNewswire

Jun. 30, 2026

Emerita Provides Update on the Progress of IBW Project’s Ongoing Prefeasibility Study

Indeterminate GlobeNewswire

Jun. 30, 2026

Lahontan Provides Santa Fe Mine Development and Exploration Update

Indeterminate GlobeNewswire

Jun. 30, 2026

Stallion Uranium Intersects Elevated Radioactivity and Alteration at Coyote; Continues Expanded Drill Program, Mobilizes Geophysical Survey

Indeterminate GlobeNewswire

Jun. 30, 2026

Azimut Provides 2026 Summer Exploration Update

Indeterminate GlobeNewswire

Jun. 30, 2026

Azimut : mise à jour sur le programme d’exploration 2026

Indeterminate GlobeNewswire